is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Informa Markets, the organiser of CPhI South East Asia, has taken the decision to reschedule the physical event that was due to take place in-person from 4-6 August 2021 at IMPACT in Bangkok to a later date. In addition, while we fully appreciate the need for our industry to remain connected and to collaborate with other members of the pharmaceutical industry in South East Asia, we have also taken the decision to postpone the online edition of CPhI South East Asia from 19 July - 13 August 2021 to 29 November – 10 December 2021.
South East Asia has been one of the relatively more successful regions in combating the spread of COVID-19. To help you understand and digest some of the more than 100 currently active COVID-19 vaccines and the hundreds of trials underway, we have summarised the most promising ones.
What does 2019 have in store for Pharma? We asked industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the market in the year ahead.
NEX is a new zone showcasing the latest natural extract products, applications and solutions. Discover the natural extract and herbal industries in Thailand from this infographic.
The governments of Indonesia and Cambodia have agreed to enhance bilateral cooperation during the visit of Cambodian Minister of Foreign Affairs Prak Sokhonn to Jakarta on Friday.
Gerresheimer has announced it will be attending CPhI South East Asia, where it will be showcasing a range of innovations and company news, including the opening of its new tubular glass production plant in India for producing MultiShell vials.
In 2019, CPhI South East Asia will take place at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand (12-14 March). CPhI South East Asia’s strategic move to Thailand will further strengthen the event’s appeal within the region.
What makes it attractive to enter the pharma market in Singapore? What are the factors fuelling growth in the pharma industry of the country? Find out more from our infographic.
To distribute this report, CPhI, the global pharma platform, is pleased to join forces with Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation. We see this report as a great way to kick off the exciting CPhI Southeast Asia event and to highlight the importance of Southeast Asia as a market for pharmaceutical companies based in Asia Pacific and worldwide. Join us on this learning journey as we drive the industry forward.
Annual revenue growth in the South East Asian pharmaceutical market is predicted to exceed 11% over the next 5 years. However, how did COVID-19 impact the industry? What are the opportunities and threats in the pharma market of the region? Find out more from our report.
“Biopharma News and Views from South East Asia: Amid challenges, the industry gains traction in Singapore, Thailand, Malaysia and Indonesia” features a series of articles on the region from BioWorld, the Clarivate Analytics biopharma news service. We see this report as a great way to kick off the exciting CPhI South East Asia event and to highlight the importance of continuous regulatory compliance within Asia Pacific and across the world.
The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.
IQVIA and CPhI are pleased to bring you our special Market Prognosis Report sharing our view of the future of the Thai pharma market. The report provides an evidence-based outlook for Thailand based on the knowledge of our country experts who carry out extensive research into key business and healthcare events.
IQVIA and CPhI are pleased to bring you our co-branded special Market Prognosis Report sharing our view of the future of the Indonesia pharma market. The report provides an evidence-based outlook for Indonesia based on the knowledge of our country experts who carry out extensive research into key business and healthcare events.
IQVIA and CPhI are pleased to bring you our co-branded special Market Prognosis Report sharing our view of the future of the Vietnam pharma market. The report provides an evidence-based outlook for Vietnam based on the knowledge of our country experts who carry out extensive research into key business and healthcare events.
As companies find new markets for their products and services, the task of managing compliance requires an intimate understanding of regulations in each and every country of operation. CPhI South East Asia is pleased to join forces with Clarivate Analytics, the leading source of intelligent information for professionals around the world. This report takes a look at five core competencies to continually ensure you are remaining regulatory compliant.
Harro Höfliger Verpackungsmaschinen GmbH is a German company specialising in the development and manufacture of customer-specific production and packaging equipment. He shared us their exhibiting experience at CPhI South East Asia in this interview.
We interviewed Kerry, the company who has been in the pharmaceutical industry for over 75 years and has earned a reputation for reliability and excellence in serving the pharmaceutical and biotechnology markets. They told us more about their developments in the Southeast Asia pharma market.